Charity Overview
SickKids is Canada’s – and one of the world’s – leading children’s hospitals. Since 1875, SickKids has been at the forefront of clinical care. Today, the hospital treat the most complex cases, for example the Labatt Family Heart Centre is one of the top three paediatric heart centres worldwide, with a 98.5% surgical survival rate. SickKids is also a renowned training centre of excellence, with its researchers at the forefront of discovery and knowledge sharing.
SickKids is incredibly grateful to ICAP Toronto for supporting its ground-breaking discoveries, cutting-edge research, innovative education and exemplary care at SickKids. ICAP’s donation has made a profound difference in the lives of children across Canada and around the world.
Here is just a glimpse at the SickKids patients, families and staff ICAP supports.
Project Summary
Research has tremendous potential to impact a child’s health by advancing new approaches to major challenges the medical profession face today. SickKids continues to be one of the largest funders of child health research in Canada, second only to the Government of Canada. With ICAP Toronto’s support SickKids is able to continue to revolutionise the field of paediatric health through life-saving and life-enhancing discoveries. With ICAP’s support following a donation from Charity Day 2013, the remarkable team of researchers, trainees and support staff at SickKids continue to advance the charity’s understanding of and ability to treat complex illnesses and injuries.
We do what we do— research at the hospital— because we want to implement change. We want to see change that impacts child healthDr. Janet Rossant, Chief of Research at the Peter Gilgan Centre for Research and Learning and Senior Scientist.
Matthew, four, was born prematurely after a routine ultrasound showed fluid in his abdomen. At birth, he tested positive for Cystic Fibrosis (CF). He was transferred to SickKids immediately to correct a bowel abnormality related to his disorder. SickKids researchers were the first in the world to use skin cells from patients with CF to produce mature lung cells in a petri dish. These cells can be used to develop and test drugs that target the genetic mutation underlying the condition. Matthew’s parents agreed to donate some of his cells in hopes of finding a cure for their son and other children with CF. Despite his health challenges, Matthew is a happy boy who brings smiles to everyone he meets. ICAP’s support helps SickKids patients like Matthew by funding critical research, learning and care.
See more of Our Impact
